Mineralys Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom | Chief Medical Officer | Option Exercise | 6,348 | $1.08 | $6,856 | 78,363 | May 13, 2024 |
| Rodman David Malcom | Chief Medical Officer | Sale | 100 | $15.00 | $1,500 | 66,997 | May 9, 2024 |
| Rodman David Malcom | Chief Medical Officer | Option Exercise | 6,349 | $1.08 | $6,857 | 66,997 | Apr 11, 2024 |
| Rodman David Malcom | Chief Medical Officer | Option Exercise | 6,348 | $1.08 | $6,856 | 55,631 | Mar 11, 2024 |
| AKKARAJU SRINIVAS | — | Award / Grant | 555,555 | $13.50 | $7,499,993 | 5,074,916 | Feb 12, 2024 |
| Samsara BioCapital, L.P. | — | Purchase | 555,555 | $13.50 | $7,499,993 | 5,074,916 | Feb 12, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | — | Award / Grant | 1,672,508 | $13.50 | $22,578,858 | 2,983,755 | Feb 12, 2024 |
| Rodman David Malcom | Chief Medical Officer | Option Exercise | 5,017 | $0.54 | $2,709 | 37,917 | Feb 12, 2024 |
| Rodman David Malcom | Chief Medical Officer | Option Exercise | 6,348 | $1.08 | $6,856 | 32,900 | Jan 11, 2024 |
| Rodman David Malcom | Chief Medical Officer | Option Exercise | 5,018 | $0.54 | $2,710 | 20,069 | Dec 11, 2023 |
| Congleton Jon | Chief Executive Officer | Purchase | 4,250 | $5.97 | $25,373 | 1,049,068 | Nov 22, 2023 |
| Rodman David Malcom | Chief Medical Officer | Option Exercise | 5,017 | $0.54 | $2,709 | 15,051 | Nov 13, 2023 |
| Rodman David Malcom | Chief Medical Officer | Option Exercise | 10,034 | $0.54 | $5,418 | 10,034 | Nov 3, 2023 |
| Congleton Jon | Chief Executive Officer | Purchase | 2,250 | $12.08 | $27,180 | 1,044,818 | Sep 6, 2023 |
| Congleton Jon | Chief Executive Officer | Purchase | 2,250 | $12.10 | $27,225 | 1,042,568 | Aug 17, 2023 |
| Congleton Jon | Chief Executive Officer | Purchase | 2,000 | $12.89 | $25,780 | 1,040,318 | Aug 11, 2023 |
| Rodman David Malcom | Chief Medical Officer | Sale | 76,182 | $12.81 | $975,891 | — | Aug 10, 2023 |
| HBM Healthcare Investments (Cayman) Ltd. | — | Purchase | 312,500 | $16.00 | $5,000,000 | 3,218,106 | Feb 14, 2023 |
| RA Capital Nexus Fund III, L.P. | — | Purchase | 1,118,400 | $16.00 | $17,894,400 | 1,311,247 | Feb 14, 2023 |
| Levy Adam Scott | CFO, Chief Bus. Off. and Secy. | Purchase | 6,250 | $16.00 | $100,000 | 350,811 | Feb 14, 2023 |
| AKKARAJU SRINIVAS | — | Purchase | 937,500 | $16.00 | $15,000,000 | 4,519,361 | Feb 14, 2023 |
| Slingsby Brian Taylor | — | C | 4,314,093 | — | — | 8,944,579 | Feb 14, 2023 |